Familial Alzheimer disease-linked mutations specifically disrupt Ca2+ leak function of presenilin 1

被引:186
作者
Nelson, Omar
Tu, Huiping
Lei, Tianhua
Bentahir, Mostafa
de Strooper, Bart
Bezprozvanny, Ilya
机构
[1] Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA
[2] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium
[3] VIB, Dept Mol & Dev Genet, Louvain, Belgium
关键词
D O I
10.1172/JCI30447
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Mutations in presenilins are responsible for approximately 40% of all early-onset familial Alzheimer disease (FAD) cases in which a genetic cause has been identified. In addition, a number of mutations in presenilin-1 (PS1) have been suggested to be associated with the occurrence of frontal temporal dementia (FTD). Presenilins are highly conserved transmembrane proteins that support cleavage of the amyloid precursor protein by gamma-secretase. Recently, we discovered that presenilins also function as passive ER Ca2+ leak channels. Here we used planar lipid bilayer reconstitution assays and Ca2+ imaging experiments with presenilin-null mouse embryonic fibroblasts to analyze ER Ca2+ leak function of 6 FAD-linked PS1 mutants and 3 known FTD-associated PS1 mutants. We discovered that L166P, A246E, E273A, G384A, and P436Q FAD mutations in PS1 abolished ER Ca2+ leak function of PS1. In contrast, A79V FAD mutation or FTD-associated mutations (L113P, G183V, and Rins352) did not appear to affect ER Ca2+ leak function of PS1 in our experiments. We validated our findings in Ca2+ imaging experiments with primary fibroblasts obtained from an FAD patient possessing mutant PS1-A246E. Our results indicate that many FAD mutations in presenilins are loss-of-function mutations affecting ER Ca2+ leak activity. In contrast, none of the FTD-associated mutations affected ER Ca2+ leak function of PSI, indicating that the observed effects are disease specific. Our observations are consistent with the potential role of disturbed Ca2+ homeostasis in Alzheimer disease pathogenesis.
引用
收藏
页码:1230 / 1239
页数:10
相关论文
共 48 条
[1]   A presenilin 1 mutation associated with familial frontotemporal dementia inhibits γ-secretase cleavage of APP and notch [J].
Amtul, Z ;
Lewis, PA ;
Piper, S ;
Crook, R ;
Baker, M ;
Findlay, K ;
Singleton, A ;
Hogg, M ;
Younkin, L ;
Younkin, SG ;
Hardy, J ;
Hutton, M ;
Boeve, BF ;
Tang-Wai, D ;
Golde, TE .
NEUROBIOLOGY OF DISEASE, 2002, 9 (02) :269-273
[2]   Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons [J].
Annaert, WG ;
Levesque, L ;
Craessaerts, K ;
Dierinck, I ;
Snellings, G ;
Westaway, D ;
George-Hyslop, PS ;
Cordell, B ;
Fraser, P ;
De Strooper, B .
JOURNAL OF CELL BIOLOGY, 1999, 147 (02) :277-294
[3]   Altered calcium homeostasis and mitochondrial dysfunction in cortical synaptic compartments of presenilin-1 mutant mice [J].
Begley, JG ;
Duan, WZ ;
Chan, S ;
Duff, K ;
Mattson, MP .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (03) :1030-1039
[4]   Presenilin clinical mutations can affect γ-secretase activity by different mechanisms [J].
Bentahir, M ;
Nyabi, O ;
Verhamme, J ;
Tolia, A ;
Horré, K ;
Wiltfang, J ;
Esselmann, H ;
De Strooper, B .
JOURNAL OF NEUROCHEMISTRY, 2006, 96 (03) :732-742
[5]   Frontotemporal dementia and parkinsonism associated with the IVSI plus IG→A mutation in progranulin:: a clinicopathologic study [J].
Boeve, Bradley F. ;
Baker, Matt ;
Dickson, Dennis W. ;
Parisi, Joseph E. ;
Giannini, Caterina ;
Josephs, Keith A. ;
Hutton, Michael ;
Pickering-Brown, Stuart M. ;
Rademakers, Rosa ;
Tang-Wai, David ;
Jack, Clifford R., Jr. ;
Kantarci, Kejal ;
Shiung, Maria M. ;
Golde, Todd ;
Smith, Glenn E. ;
Geda, Yonas E. ;
Knopman, David S. ;
Petersen, Ronald C. .
BRAIN, 2006, 129 :3103-3114
[6]   Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population based study of presenile Alzheimer disease [J].
Cruts, M ;
van Duijn, CM ;
Backhovens, H ;
Van den Broeck, M ;
Wehnert, A ;
Serneels, S ;
Sherrington, R ;
Hutton, M ;
Hardy, J ;
St George-Hyslop, PH ;
Hofman, A ;
Van Broeckhoven, C .
HUMAN MOLECULAR GENETICS, 1998, 7 (01) :43-51
[7]   Evidence that Aβ42 plasma levels in presenilin-1 mutation carriers do not allow for prediction of their clinical phenotype [J].
De Jonghe, C ;
Cras, P ;
Vanderstichele, H ;
Cruts, M ;
Vanderhoeven, I ;
Smouts, I ;
Vanmechelen, E ;
Martin, JJ ;
Hendriks, L ;
Van Broeckhoven, C .
NEUROBIOLOGY OF DISEASE, 1999, 6 (04) :280-287
[8]   Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein [J].
De Strooper, B ;
Saftig, P ;
Craessaerts, K ;
Vanderstichele, H ;
Guhde, G ;
Annaert, W ;
Von Figura, K ;
Van Leuven, F .
NATURE, 1998, 391 (6665) :387-390
[9]   Loss-of-function presenilin mutations in Alzheimer disease - Talking Point on the role of presenilin mutations in Alzheimer disease [J].
De Strooper, Bart .
EMBO REPORTS, 2007, 8 (02) :141-146
[10]  
DEMPSTER J, 2001, LAB COMPUTE PRACTICA